{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:41:51Z","timestamp":1784569311191,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":38,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nefroe.2025.101324","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:17:47Z","timestamp":1754579867000},"page":"101324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Particularities of peritoneal dialysis in diabetic patients"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2746-4502","authenticated-orcid":false,"given":"Vit\u00f3ria Paes","family":"de Faria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rute","family":"Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Carlos","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Clara","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Marta","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2025.101324_bib0270","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.tem.2021.06.001","article-title":"Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis","volume":"32","author":"Lambie","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.nefroe.2025.101324_bib0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000514550","article-title":"Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy","volume":"52","author":"Thurlow","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0280","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.ki.5001910","article-title":"Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us?","author":"Vonesh","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nefroe.2025.101324_bib0285","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000439193","article-title":"Peritoneal dialysis in Asia","volume":"1","author":"Kwong","year":"2015","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.nefroe.2025.101324_bib0290","doi-asserted-by":"crossref","first-page":"22","DOI":"10.23876\/j.krcp.2017.36.1.22","article-title":"A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival","volume":"36","author":"Kim","year":"2017","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.nefroe.2025.101324_bib0295","first-page":"289","article-title":"Diabetes mellitus and dialysis","volume":"56","author":"Stein","year":"2004","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0300","series-title":"Modalities of RRT: renal replacement therapy and conservative management: evidence review","article-title":"NICE Evidence Reviews Collection","year":"2018"},{"key":"10.1016\/j.nefroe.2025.101324_bib0305","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/0886022X.2019.1625788","article-title":"Comparison of peritoneal dialysis with hemodialysis on survival of diabetic patients with end-stage kidney disease: a meta-analysis of cohort studies","volume":"41","author":"Xue","year":"2019","journal-title":"Ren Fail"},{"key":"10.1016\/j.nefroe.2025.101324_bib0310","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/0886022X.2021.1918558","article-title":"Risk factors for mortality in patients undergoing peritoneal dialysis: a systematic review and meta-analysis","volume":"43","author":"Zhang","year":"2021","journal-title":"Ren Fail"},{"key":"10.1016\/j.nefroe.2025.101324_bib0315","first-page":"e61201","article-title":"Metabolic syndrome increases mortality risk in dialysis patients: a systematic review and meta-analysis","volume":"16","author":"Sanguankeo","year":"2018","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.nefroe.2025.101324_bib0320","doi-asserted-by":"crossref","first-page":"1116103","DOI":"10.3389\/fmed.2023.1116103","article-title":"Chinese experience on comparison of clinical efficacy and safety of hemodialysis and peritoneal dialysis in the treatment of diabetic kidney failure: a systematic review and meta-analysis","volume":"10","author":"Wei","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.nefroe.2025.101324_bib0325","first-page":"28","article-title":"Diabetes and end-stage renal disease; a review article on new concepts","volume":"4","author":"Ghaderian","year":"2015","journal-title":"J Renal Inj Prev"},{"key":"10.1016\/j.nefroe.2025.101324_bib0330","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ndt\/17.1.112","article-title":"Initial survival advantage of peritoneal dialysis relative to haemodialysis","volume":"17","author":"Heaf","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2025.101324_bib0335","doi-asserted-by":"crossref","first-page":"133","DOI":"10.17219\/acem\/76751","article-title":"Mortality predictor pattern in hemodialysis and peritoneal dialysis in diabetic patients","volume":"28","author":"Klinger","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.nefroe.2025.101324_bib0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000525676","article-title":"Can the use of continuous glucose monitoring improve glycemic control in patients with type 1 and 2 diabetes receiving dialysis?","volume":"147","author":"Bomholt","year":"2023","journal-title":"Nephron"},{"key":"10.1016\/j.nefroe.2025.101324_bib0345","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nefroe.2025.101324_bib0350","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/1744-9987.12166","article-title":"Hemoglobin A1c in patients on peritoneal dialysis: how should we interpret it?","volume":"18","author":"Coelho","year":"2014","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.nefroe.2025.101324_bib0355","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","volume":"102","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2025.101324_bib0360","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nefroe.2025.101324_bib0365","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1038\/s41598-019-39933-5","article-title":"Glycemic control and survival in peritoneal dialysis patients with diabetes: a 2-year nationwide cohort study","volume":"9","author":"Abe","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nefroe.2025.101324_bib0370","doi-asserted-by":"crossref","first-page":"e30072","DOI":"10.1371\/journal.pone.0030072","article-title":"Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study","volume":"7","author":"Yoo","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.nefroe.2025.101324_bib0375","doi-asserted-by":"crossref","first-page":"e0262880","DOI":"10.1371\/journal.pone.0262880","article-title":"Long-term glycemic variability and the risk of mortality in diabetic patients receiving peritoneal dialysis","volume":"17","author":"Afghahi","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.nefroe.2025.101324_bib0380","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2215\/CJN.08921010","article-title":"Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus","volume":"6","author":"Duong","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0385","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ekir.2023.01.040","article-title":"Narrative review of glycemic management in people with diabetes on peritoneal dialysis","volume":"8","author":"Wijewickrama","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.nefroe.2025.101324_bib0390","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000371554","article-title":"The benefit of a glucose-sparing PD therapy on glycemic control measured by serum fructosamine in diabetic patients in a randomized, controlled trial (IMPENDIA)","volume":"129","author":"Li","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.nefroe.2025.101324_bib0395","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/hdi.12312","article-title":"The Glycemic Indices in Dialysis Evaluation (GIDE) study: comparative measures of glycemic control in diabetic dialysis patients","volume":"19","author":"Williams","year":"2015","journal-title":"Hemodial Int"},{"key":"10.1016\/j.nefroe.2025.101324_bib0400","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ki.2008.25","article-title":"Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis","volume":"73","author":"Peacock","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2025.101324_bib0405","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1463-1326.2007.00802.x","article-title":"Insulin therapy in renal disease","volume":"10","author":"Iglesias","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.nefroe.2025.101324_bib0410","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/phar.2659","article-title":"Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis","volume":"42","author":"Blaine","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nefroe.2025.101324_bib0415","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.25011\/cim.v35i3.16589","article-title":"Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials","volume":"35","author":"Almalki","year":"2012","journal-title":"Clin Investig Med"},{"key":"10.1016\/j.nefroe.2025.101324_bib0420","first-page":"10","article-title":"Management of kidney failure in patients with diabetes mellitus: what are the best options?","author":"Buades","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.nefroe.2025.101324_bib0425","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patient with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2025.101324_bib0430","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2025.101324_bib0435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/08968608221096556","article-title":"The rationale for the need to study sodium-glucose co-transport 2 inhibitor usage in peritoneal dialysis patients","volume":"43","author":"Borkum","year":"2023","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nefroe.2025.101324_bib0440","article-title":"Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design","author":"Barreto","year":"2023","journal-title":"Res Sq"},{"key":"10.1016\/j.nefroe.2025.101324_bib0445","unstructured":"The effects of dapagliflozin on ultrafiltration among peritoneal dialysis patients. ClinicalTrials.gov identifier: NCT04923295. [accessed 16.10.23]."},{"key":"10.1016\/j.nefroe.2025.101324_bib0450","unstructured":"Reduction of peritoenal glucose uptake with use of SGLT2 in humans undergoing peritoneal dialysis treatment (PRESERVE). ClinicalTrials.gov identifier: NCT05250752. [accessed 16.10.23]."},{"key":"10.1016\/j.nefroe.2025.101324_bib0455","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211048663","article-title":"Diabetes mellitus in dialysis and renal transplantation","volume":"12","author":"Ben-David","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.nefroe.2025.101324_bib0460","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s42003-021-01652-x","article-title":"Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis","volume":"4","author":"Li","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0465","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3747\/pdi.2011.00116","article-title":"Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients \u2013 a randomized crossover trial","volume":"32","author":"Li","year":"2012","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nefroe.2025.101324_bib0470","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1111\/bcp.14107","article-title":"Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis","volume":"85","author":"Abdel Shaheed","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0475","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40620-020-00804-2","article-title":"The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis","volume":"34","author":"Bonomini","year":"2021","journal-title":"J Nephrol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0480","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.02380218","article-title":"Biocompatible solutions and long-term changes in peritoneal solute transport","volume":"13","author":"Elphick","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0485","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/sdi.12579","article-title":"\u201cBiocompatible\u201d neutral pH low-GDP peritoneal dialysis solutions: much ado about nothing?","volume":"30","author":"Misra","year":"2017","journal-title":"Semin Dial"},{"key":"10.1016\/j.nefroe.2025.101324_bib0490","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2012100987","article-title":"Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients","volume":"24","author":"Li","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0495","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/089686080902900409","article-title":"Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients","volume":"29","author":"Paniagua","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nefroe.2025.101324_bib0500","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.10041110","article-title":"Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial","volume":"6","author":"Takatori","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0505","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2215\/CJN.03630807","article-title":"Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology","volume":"3","author":"Honda","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0510","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000477829","article-title":"Peritoneal water transport characteristics of diabetic patients undergoing peritoneal dialysis: a longitudinal study","volume":"46","author":"Fernandes","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefroe.2025.101324_bib0515","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4103\/0366-6999.154275","article-title":"Influence of peritoneal transport characteristics on nutritional status and clinical outcome in Chinese diabetic nephropathy patients on peritoneal dialysis","volume":"128","author":"Guan","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.nefroe.2025.101324_bib0520","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3747\/PDI.2012.00185","article-title":"Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis","volume":"34","author":"Rodr\u00edguez-Carmona","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nefroe.2025.101324_bib0525","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4239\/wjd.v11.i10.435","article-title":"Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: a multicenter retrospective cohort study","volume":"11","author":"Meng","year":"2020","journal-title":"World J Diabetes"},{"key":"10.1016\/j.nefroe.2025.101324_bib0530","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3747\/pdi.2012.00111","article-title":"Better outcomes of peritoneal dialysis in diabetic patients in spite of risk of loss of autonomy for home dialysis","volume":"34","author":"Cotovio","year":"2014","journal-title":"Perit Dial Int"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425000847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425000847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:08:21Z","timestamp":1757106501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251425000847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2013251425000847"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.101324","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Particularities of peritoneal dialysis in diabetic patients","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.101324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Nefrolog\u00eda.","name":"copyright","label":"Copyright"}],"article-number":"101324"}}